| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |